Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,202 shares at $142.24 ($582K) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Scheduled sale ($582k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.24 | 1,121 | $159K | 27.4% |
| 2 | $142.24 | 1,121 | $159K | 27.4% |
| 3 | $134.21 | 980 | $132K | 22.6% |
| 4 | $134.21 | 980 | $132K | 22.6% |
| Total | $138.49 avg | 4,202 | $582K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-02 | $410K | — | Filing → |